NCT07297173 2025-12-22Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R LeukemiaBeijing 302 HospitalPhase 1 Recruiting5 enrolled